Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 50.70
+0.04 (0.08%)
May 13, 2025, 3:00 PM CST
Cathay Biotech Revenue
Cathay Biotech had revenue of 775.77M CNY in the quarter ending March 31, 2025, with 13.33% growth. This brings the company's revenue in the last twelve months to 3.05B, up 32.96% year-over-year. In the year 2024, Cathay Biotech had annual revenue of 2.96B with 39.91% growth.
Revenue (ttm)
3.05B
Revenue Growth
+32.96%
P/S Ratio
11.98
Revenue / Employee
1.76M
Employees
1,735
Market Cap
36.54B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wanhua Chemical Group | 178.98B |
| Baoshan Iron & Steel | 314.18B |
| Shandong Gold Mining | 89.50B |
| Ningxia Baofeng Energy Group | 35.53B |
| Hengli Petrochemical | 235.00B |
| China Northern Rare Earth (Group) High-Tech Co.,Ltd | 36.49B |
| Qinghai Salt Lake Industry Co.,Ltd | 15.53B |
| Rongsheng Petrochemical | 320.36B |